ATC level 4
J05AREfavirenz/lamivudine/tenofovir
- Molecules
- 19
- Subgroups
- 16
ATC J05AR (Efavirenz/lamivudine/tenofovir) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 19 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
- J05AR01Lamivudine and Zidovudine1
- J05AR02Abacavir and Lamivudine1
- J05AR03Emtricitabine and Tenofovir disoproxil1
- J05AR04Abacavir, Lamivudine and Zidovudine1
- J05AR06Efavirenz, Emtricitabine and Tenofovir disoproxil1
- J05AR08Emtricitabine, Rilpivirine and Tenofovir disoproxil1
- J05AR09Cobicistat, Elvitegravir, Emtricitabine and Tenofovir disoproxil1
- J05AR10Lopinavir and Ritonavir1
- J05AR13Abacavir, Dolutegravir and Lamivudine1
- J05AR14Cobicistat and Darunavir1
- J05AR15Atazanavir and Cobicistat1
- J05AR17Emtricitabine and Tenofovir alafenamide1
- J05AR19Emtricitabine, Rilpivirine and Tenofovir alafenamide1
- J05AR20Bictegravir, Emtricitabine and Tenofovir alafenamide1
- J05AR21Dolutegravir and Rilpivirine1
- J05AR22Cobicistat, Darunavir, Emtricitabine and Tenofovir alafenamide1
Molecules
Molecules with an ATC code under J05AR.
- Abacavir and LamivudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR02
- Abacavir, Dolutegravir and LamivudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR13
- Abacavir, Lamivudine and ZidovudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentationJ05AR04
- Atazanavir and CobicistatCytochrome P450 3A Inhibitor1 presentation2 brandsJ05AR15
- Bictegravir, Emtricitabine and Tenofovir alafenamideOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations2 brandsJ05AR20
- Cobicistat and DarunavirJ05AR14
- Cobicistat, Darunavir, Emtricitabine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR22
- Cobicistat, Elvitegravir, Emtricitabine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR
- Cobicistat, Elvitegravir, Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation2 brandsJ05AR09
- Dolutegravir and LamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR
- Dolutegravir and RilpivirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR21
- Doravirine, Lamivudine and Tenofovir disoproxilHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AR
- Efavirenz, Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation3 brandsJ05AR06
- Emtricitabine and Tenofovir alafenamideOrphanHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations3 brandsJ05AR17
- Emtricitabine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8 presentations6 brandsJ05AR03
- Emtricitabine, Rilpivirine and Tenofovir alafenamideHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation3 brandsJ05AR19
- Emtricitabine, Rilpivirine and Tenofovir disoproxilHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations2 brandsJ05AR08
- Lamivudine and ZidovudineHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2 presentations1 brandJ05AR01
- Lopinavir and RitonavirProtease Inhibitor5 presentations3 brandsJ05AR10
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.